drugset / Trial / NCT00807846

A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects

NCT00807846

Phase 4 Completed 201 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This Is A Multicenter, Active-Controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis

Timeline

Start
2009-09
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 50 mg Oral
Subject Celecoxib Other / unclassified 100 mg Oral
Subject Naproxen Small molecule 7.5 mg/kg Oral